标题
Rituximab in multiple sclerosis at general hospital level
作者
关键词
-
出版物
ACTA NEUROLOGICA SCANDINAVICA
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-29
DOI
10.1111/ane.13225
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
- (2018) S. G. Berntsson et al. ACTA NEUROLOGICA SCANDINAVICA
- A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma
- (2018) Pallawi Torka et al. Clinical Lymphoma Myeloma & Leukemia
- Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
- (2018) Carmen Alcalá et al. JOURNAL OF NEUROLOGY
- Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes
- (2018) Fredrik Piehl et al. Multiple Sclerosis Journal
- Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
- (2018) Barbara Scotti et al. PLoS One
- Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
- (2018) Mathias Granqvist et al. JAMA Neurology
- Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes
- (2018) Fredrik Piehl et al. Multiple Sclerosis Journal
- Severe neutropenia after rituximab-treatment of multiple sclerosis
- (2018) Eero Rissanen et al. Multiple Sclerosis and Related Disorders
- Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases
- (2018) Thomas Roux et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
- (2018) Bassem I. Yamout et al. Journal of Immunology Research
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab associated late-onset neutropenia—a rheumatology case series and review of the literature
- (2016) William E. Monaco et al. CLINICAL RHEUMATOLOGY
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections
- (2011) Daniel Tesfa et al. ARTHRITIS AND RHEUMATISM
- The clinical application of monoclonal antibodies in chronic lymphocytic leukemia
- (2010) S. M. Jaglowski et al. BLOOD
- Late-Onset Neutropenia After Rituximab Treatment
- (2010) Ofir Wolach et al. MEDICINE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started